GPX Medical in Media

We develop technology for improving the care and life quality of our most vulnerable patients – preterm born infants.

GPX Medical publicerar investerarbrev

GPX Medical AB (publ) publicerar ett investerarbrev för sommaren 2021 I sommarens nummer får ni läsa en sommarhälsning från VD Hanna Sjöström och om försäljningen av det första NEOLA®-systemet till Tyndall National Institute på University College Cork som kommer...

GPX Medical has Sold its First NEOLA® System to Tyndall National Institute at University College Cork to be used for a large Study on Newborn Infants within The Irish Centre for Maternal and Child Health Research in Ireland

Tyndall National Institute at University College Cork in Ireland (UCC) will aquire a NEOLA® system from GPX Medical AB (publ) in order to launch a large study on newborn infants at the research facility at Cork University Maternity Hospital. This study will be...

For Investors

We are on a journey to revolutionize neonatal intensive care
Learn more about investing in GPX Medical

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:


GPX Medical AB (publ)
Tellusgatan 13
224 57 Lund

Organization number: 559069-9012